ChemDraw Connect - June 10, 2026
|Unifying Drug Modalities: A Smarter Way to Design Small Molecules, Peptides, Oligos and Antibodies
Today’s pipelines span everything from classic small molecules to complex biologics and conjugates, yet scientists still struggle to handle them all in a coherent way. This session explores how you can handle these diverse modalities side‑by‑side in Signals ChemDraw and Signals Notebook, with real, approved drugs as concrete examples.- Small molecules: follow well‑known approved drugs from clean structure capture through annotation and reuse in modern workflows
- Peptides and artificial peptides: see how custom monomers and sequence‑based representations map onto real peptide drugs on the market
- Oligonucleotides, antibodies and ADCs: explore approved ASOs, siRNA, antibodies and antibody–drug conjugates, and how to represent their full complexity in day‑to‑day project work
